Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor-like Kinase-1 Ligand Trap, in Patients with Advanced Cancer

Published 2013 View Full Article

Authors

Keywords

Journal

CLINICAL CANCER RESEARCH

Volume 20, Issue 2, Pages 480-489

Publisher

American Association for Cancer Research (AACR)

Online

2013-10-31

DOI

10.1158/1078-0432.ccr-13-1840

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

CLINICAL CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Create your own webinar